Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his upcoming session, “Better Care for Psoriasis Patients,” to be presented at Dermatology Week Fall 2023.
In this feature video, Drs Maderal and Vazquez discuss their recent review on how insurance approval and the need for prior authorization can be barriers to care for patients with psoriatic disease.
In this feature video, Drs Maderal and Vazquez discuss their recent review on how insurance approval and the need for prior authorization can be barriers to care for patients with psoriatic disease.
In this interview, Ron Vender, MD, FRCPC, discusses why patients with psoriasis have a decreased quality of life no matter where they have skin involvement.
In this interview, Ron Vender, MD, FRCPC, discusses why patients with psoriasis have a decreased quality of life no matter where they have skin involvement.
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
At Fall Dermatology Week, Dr Susan Taylor highlighted significant progress in vitiligo treatment, focusing on Janus kinase inhibitors and their potential for repigmentation.
At Fall Dermatology Week, Dr Susan Taylor highlighted significant progress in vitiligo treatment, focusing on Janus kinase inhibitors and their potential for repigmentation.
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
